Matthew Charles McMurdo's Net Worth

$670 Thousand

Estimate Recalculated Nov 1, 2024 05:17AM EST

Who is Matthew Charles McMurdo?

Matthew Charles McMurdo does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include TITAN PHARMACEUTICALS INC, MINIM, INC., and OPGEN INC.

SEC CIK

Matthew Charles McMurdo's CIK is 0001943108

Past Insider Trading and Trends

2023 was Matthew Charles McMurdo's most active year for acquiring shares with 7 total transactions. Matthew Charles McMurdo's most active month to acquire stocks was the month of May. 2023 saw Matthew Charles McMurdo paying a total of $0.00 for 366,250 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

TITAN PHARMACEUTICALS INC (TTNP) Snapshot price: $5.8297

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+32.50%
16.25K
—
—
66.25K
Oct 25
Form 4/A
∞
50K
—
—
50K
Jun 29 - Jul 26
Form 4
∞
50K
—
—
50K
Jun 29 - Jul 26
Form 3
—
0
—
—
0
No matching records found

MINIM, INC. (MINM) Snapshot price: $3.14

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
25K
—
—
25K
Jan 22
Form 3
—
0
—
—
0
No matching records found

OPGEN INC (OPGN) Snapshot price: $2.05

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
100K
—
—
100K
Apr 11
Form 3
—
0
—
—
0
No matching records found